Magnesium valproate

ไธ™ๆˆŠ้…ธ้•

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMagnesium valproate
Drug Alias Namemagnesium 2-propylpentanoate2-ไธ™ๅŸบๆˆŠ้…ธ้•Magnesium dipropylacetateไธ™ๆˆŠ้…ธ้•็ผ“้‡Š็‰‡ไธ™ๆˆŠ้…ธ้•็‰‡ +[7]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 inhibitorsGamma-amino-N-butyrate transaminase inhibitors
TargetsGamma-amino-N-butyrate transaminaseGlycogen synthase kinase-3
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsEpilepsy
Approved Indications in ChinaEpilepsy
Original Approved Country/TerritoryMainland China
Original Approved Date1989/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHunan Xiangzhong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHunan Xiangzhong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN03A
Related LinksN/A